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INTRODUCTION: The prevention of infections 
disease represents nowadays a central need, 
especially for prosthetic surgery. Many nosocomial 
bacteria, in fact, show an increasing resistance 
towards antibiotics, causing serious infections that 
lead to prolonged times of hospitalisation. The 
development of surfaces with low bacterial 
adhesion together with biocompatibility can 
represent a solution to prevent infections. 
Biocompatible glasses can be used to realize bone 
substitutes as well as coated metallic devices; 
moreover such materials can be opportunely 
treated to enrich their surfaces with silver ions [1] 
thus providing a controlled ion release and 
consequently antibacterial efficacy. Silver is, in 
fact, a well-known broad-spectrum antimicrobial 
agent, so silver-doped glasses can be produced to 
realize different devices, such as bone substitutes 
or coated metallic implants, with antibacterial 
action.  
METHODS: A biocompatible glass composition 
was selected, processed by ion-exchange treatment 
to introduce a controlled amount of silver ions on 
its surface and, finally, characterized in terms of 
silver release in simulated body fluid solution (GF-
AAS) and antibacterial activity (S. Aureus and E. 
Coli). Release tests were performed analyzing SBF 
at increasing times of contact with silver doped 
glass samples. Antibacterial tests evaluated 
bacteria adhesion on silver containing samples 
surfaces compared with untreated glass and PE 
control by means of colony forming unit (CFU) 
counts; moreover also culture medium was 
examined after samples incubation. 
RESULTS: GF-AAS tests results are graphically 
shown in figure 1: the maximum amount of 
released silver ions is below 2µg/cm2; release rate 
is higher for shorter times of SBF exposure to 
silver doped samples, reaching a threshold after 
about 500 hours. Antibacterial tests demonstrate, 
as evident in figure 2 (only S. Aureus results are 
reported), that the introduced silver amount is 
sufficient to guarantee an antibacterial activity 
towards both S. Aureus and E. Coli. 
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Fig. 1: GF-AAS measurements of silver ions 
released from doped glass samples into SBF 
solution. 
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Fig. 2: C.F.U. counts after 24 hours incubation of 
S. Aureus on PE control (white bars), untreated 
glass (blue bars) and silver doped glass(yellow 
bars); both bacteria adhered on material surface 
and proliferated into culture medium were 
counted. 
DISCUSSION & CONCLUSIONS: Release tests 
results are in accordance with literature data 
concerning safe concentrations for silver. 
Moreover the release rate trend shows that the 
stronger activity of silver is obtained immediately 
after contact with SBF solution; commonly, higher 
risks of infections occur immediately after surgical 
operations. Antibacterial tests demonstrates that 
silver doped glasses prepared by ion-exchange 
treatment are effective against S. Aureus and E. 
Coli adhesion onto material surface and 
proliferation in the surrounding culture medium: in 
both cases, in fact, C.F.U. decreased of at least 2 
order of magnitude respect to control samples.  
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